Research Article
Biosynthesis of Copper Oxide Nanoparticles Using Streptomyces MHM38 and Its Biological Applications
Table 2
Effect of copper oxide nanoparticles produced using Streptomyces sp. MHM38 on biochemical parameters.
| | Groups | Control | PAC | CuONPs (1 mg/kg b.wt) | CuONPs (2 mg/kg b.wt) | CuONPs (5 mg/kg b.wt) | CuONPs (1 mg/kg b.wt)+PAC | CuONPs (2 mg/kg b.wt)+PAC | CuONPs (5 mg/kg b.wt)+PAC | | Parameters |
| | ALT (U/l) | | | b | b | b | ab | ab | ab | | AST (U/l) | | a | b | b | b | ab | ab | ab | | ALP (U/l) | | a | b | b | b | ab | ab | ab | | Total bilirubin (mg/dl) | | a | b | b | b | ab | ab | ab | | Direct bilirubin (mg/dl) | | a | b | b | b | ab | ab | ab | | Urea (mg/dl) | | a | b | b | b | ab | ab | ab | | Creatinine (mg/dl) | | a | b | b | b | ab | ab | ab | | LDH (U/l) | | a | b | b | b | ab | ab | ab |
|
|
Results are expressed as the ( ) where the mean is significant at . aCompared with the control group; bcompared with the paracetamol group. |
